Pharmacy Daily | Voltaren’s $15m spend

NOVARTIS has announced a $15 million Voltaren marketing and education campaign, designed to help both pharmacists and consumers understand the issues surrounding the appropriate usage of Voltaren’s over the counter analgesics range. The spend effectively doubles the company’s 2009 Voltaren brand investment and from today, will see pharmacies offered a series of faceto- face education and training programs as well as in-store promotions designed specifically to enhance product understanding, and refresh OTC pain management knowledge. Novartis’ consumer push will also this month see Aussie basketball superstar Andrew Gaze become the face of a brand new Voltaren television commercial and point of sale campaign. Products featured will include Voltaren Rapid 12.5 tablets and Voltaren Emulgel, with a particular focus on Voltarin Rapid 25 as a stronger pain relief option following the recent codeine rescheduling. For more info on the campaign or stock ordering call 1300 667 558.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jun 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jun 10